Predicting the structure of protein complexes: a step in the right direction.
暂无分享,去创建一个
[1] D. Koshland,et al. Prediction of the structure of a receptor–protein complex using a binary docking method , 1992, Nature.
[2] J. Janin,et al. Protein‐protein recognition analyzed by docking simulation , 1991, Proteins.
[3] E. Katchalski‐Katzir,et al. Molecular surface recognition: determination of geometric fit between proteins and their ligands by correlation techniques. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[4] Ronald Breslow,et al. Molecular recognition , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[5] M. Lawrence,et al. CLIX: A search algorithm for finding novel ligands capable of binding proteins of known three‐dimensional structure , 1992, Proteins.
[6] PatrickY.-S. Lam,et al. Rational design of potent, bioavailable, nonpeptide cyclic ureas as HIV protease inhibitors. , 1994, Science.
[7] J. Ponder,et al. Tertiary templates for proteins. Use of packing criteria in the enumeration of allowed sequences for different structural classes. , 1987, Journal of molecular biology.
[8] Regine Bohacek,et al. Multiple Highly Diverse Structures Complementary to Enzyme Binding Sites: Results of Extensive Application of a de Novo Design Method Incorporating Combinatorial Growth , 1994 .
[9] P. Goodford. A computational procedure for determining energetically favorable binding sites on biologically important macromolecules. , 1985, Journal of medicinal chemistry.
[10] S. Kim,et al. "Soft docking": matching of molecular surface cubes. , 1991, Journal of molecular biology.
[11] J. Cherfils,et al. Molecular docking programs successfully predict the binding of a β-lactamase inhibitory protein to TEM-1 β-lactamase , 1996, Nature Structural Biology.
[12] Conrad C. Huang,et al. Automated site-directed drug design using molecular lattices , 1992 .
[13] A Caflisch,et al. Monte Carlo docking of oligopeptides to proteins , 1992, Proteins.
[14] André Matagne,et al. Structural and kinetic characterization of a β-lactamase-inhibitor protein , 1994, Nature.
[15] M. L. Connolly. Solvent-accessible surfaces of proteins and nucleic acids. , 1983, Science.
[16] C. Chothia,et al. The structure of protein-protein recognition sites. , 1990, The Journal of biological chemistry.
[17] W. Howe,et al. Computer design of bioactive molecules: A method for receptor‐based de novo ligand design , 1991, Proteins.
[18] D. Goodsell,et al. Automated docking of substrates to proteins by simulated annealing , 1990, Proteins.
[19] M. Lewis,et al. Calculation of the free energy of association for protein complexes , 1992, Protein science : a publication of the Protein Society.
[20] M. L. Connolly. Shape complementarity at the hemoglobin alpha 1 beta 1 subunit interface. , 1986, Biopolymers.
[21] M J Sternberg,et al. A continuum model for protein-protein interactions: application to the docking problem. , 1995, Journal of molecular biology.
[22] B. Honig,et al. Calculation of electrostatic potentials in an enzyme active site , 1987, Nature.
[23] Paul A. Bartlett,et al. Caveat a program to facilitate the structure derived design of biologically active molecules , 1989 .
[24] D. M. Ryan,et al. Rational design of potent sialidase-based inhibitors of influenza virus replication , 1993, Nature.
[25] F. Crick,et al. The packing of α‐helices: simple coiled‐coils , 1953 .
[26] F E Cohen,et al. Structure-based inhibitor design by using protein models for the development of antiparasitic agents. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[27] L. Kuyper,et al. High-affinity inhibitors of dihydrofolate reductase: antimicrobial and anticancer activities of 7,8-dialkyl-1,3-diaminopyrrolo[3,2-f]quinazolines with small molecular size. , 1996, Journal of medicinal chemistry.
[28] J. Janin,et al. Computer analysis of protein-protein interaction. , 1978, Journal of molecular biology.
[29] Elaine C. Meng,et al. Structure of a non-peptide inhibitor complexed with HIV-1 protease. Developing a cycle of structure-based drug design. , 1997 .
[30] I D Kuntz,et al. Structure of a non-peptide inhibitor complexed with HIV-1 protease. Developing a cycle of structure-based drug design. , 1997, The Journal of biological chemistry.
[31] J. Zou,et al. Improved methods for building protein models in electron density maps and the location of errors in these models. , 1991, Acta crystallographica. Section A, Foundations of crystallography.
[32] J Moult,et al. Docking by least-squares fitting of molecular surface patterns. , 1992, Journal of molecular biology.
[33] D K Gehlhaar,et al. De novo design of enzyme inhibitors by Monte Carlo ligand generation. , 1995, Journal of medicinal chemistry.
[34] W F van Gunsteren,et al. Can the stability of protein mutants be predicted by free energy calculations? , 1993, Protein engineering.
[35] J. Janin,et al. Protein-protein recognition. , 1995, Progress in biophysics and molecular biology.
[36] I. Kuntz,et al. Protein docking and complementarity. , 1991, Journal of molecular biology.
[37] S. Freer,et al. Design of enzyme inhibitors using iterative protein crystallographic analysis. , 1991, Journal of medicinal chemistry.
[38] Dagmar Ringe,et al. Analogous inhibitors of elastase do not always bind analogously , 1994, Nature Structural Biology.
[39] J A McCammon,et al. Theoretical calculations of relative affinities of binding. , 1991, Methods in enzymology.
[40] I. Kuntz,et al. Structure-based discovery of inhibitors of thymidylate synthase. , 1993, Science.
[41] R. Read,et al. A multiple-start Monte Carlo docking method. , 1992, Proteins.
[42] M. Karplus,et al. Functionality maps of binding sites: A multiple copy simultaneous search method , 1991, Proteins.
[43] I D Kuntz,et al. Inhibition of the fusion-inducing conformational change of influenza hemagglutinin by benzoquinones and hydroquinones. , 1993, Biochemistry.
[44] J. Janin,et al. Computer studies of interactions between macromolecules. , 1987, Progress in biophysics and molecular biology.
[45] J. Janin,et al. Rigid‐body docking with mutant constraints of influenza hemagglutinin with antibody HC19 , 1994, Proteins.
[46] L. Pauling,et al. THE NATURE OF THE INTERMOLECULAR FORCES OPERATIVE IN BIOLOGICAL PROCESSES. , 1940, Science.
[47] S E Ealick,et al. Structure-based design of inhibitors of purine nucleoside phosphorylase. , 1995, Acta crystallographica. Section D, Biological crystallography.
[48] I. Kuntz,et al. Structure-based design of nonpeptide inhibitors specific for the human immunodeficiency virus 1 protease. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[49] Hans-Joachim Böhm,et al. The computer program LUDI: A new method for the de novo design of enzyme inhibitors , 1992, J. Comput. Aided Mol. Des..
[50] H. Wolfson,et al. Molecular surface recognition by a computer vision-based technique. , 1994, Protein engineering.
[51] Ruben Abagyan,et al. Detailed ab initio prediction of lysozyme–antibody complex with 1.6 Å accuracy , 1994, Nature Structural Biology.